Showing results (1461-1470 of 1,480) with videos related to

Sort By:
Pageof 148
Lupus|May 4, 2004
Autologous stem cell transplantation for systemic lupus erythematosusDavid Jayne, Jacob Passweg, Alberto Marmont, et al.
Acta Pharmacologica Sinica|June 23, 2026
Clemastine alleviates cognitive dysfunction after SAH by targeting neuronal CNTN1 to regulate the ADA-adenosine pathwayLong-Xiang Li, Bo-Yang Wei, Lei Jin, et al.
Surgical Endoscopy|December 1, 2020
Evaluating the advantages of treating acute cholecystitis by following the Tokyo Guidelines 2018 (TG18): a study emphasizing clinical outcomes and medical expendituresYu-Ning Lin, Yu-Tung Wu, Chih-Yuan Fu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 27, 2023
Phenotypic Heterogeneity in Patients with Mutations in the Mitochondrial Complex I Assembly Gene NDUFAF5Pin-Shiuan Chen, Ni-Chung Lee, Chieh-Ju Sung, et al.
The Prostate|September 17, 2013
Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese menRong Na, Fang Liu, Penyin Zhang, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 19, 2019
Evidence of Spin Frustration in a Vanadium Diselenide Monolayer MagnetPing Kwan Johnny Wong, Wen Zhang, Fabio Bussolotti, et al.
Journal of Ethnopharmacology|April 10, 2022
Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trialHuan-Ming Xiao, Mei-Jie Shi, Jun-Min Jiang, et al.
Nature Biotechnology|June 11, 2024
Crowd-sourced benchmarking of single-sample tumor subclonal reconstructionAdriana Salcedo, Maxime Tarabichi, Alex Buchanan, et al.
Blood|September 10, 2024
Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPNEdimara S Reis, Rebecca Buonpane, Hamza Celik, et al.
Clinical Transplantation|October 26, 2025
The Eastern Cooperative Oncology Group Score Rather Than Donor Type Impacts Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia Patients Aged 51-60 Years: A Retrospective Study From the Chinese Blood and Marrow Transplant RegistryXin Zhao, Ming Zhou, Bao-Dong Ye, et al.
Pageof 148